BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14508078)

  • 1. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.
    Fisher PB; Gopalkrishnan RV; Chada S; Ramesh R; Grimm EA; Rosenfeld MR; Curiel DT; Dent P
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S23-37. PubMed ID: 14508078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.
    Lebedeva IV; Sarkar D; Su ZZ; Kitada S; Dent P; Stein CA; Reed JC; Fisher PB
    Oncogene; 2003 Nov; 22(54):8758-73. PubMed ID: 14647471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.
    Fisher PB; Sarkar D; Lebedeva IV; Emdad L; Gupta P; Sauane M; Su ZZ; Grant S; Dent P; Curiel DT; Senzer N; Nemunaitis J
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):300-7. PubMed ID: 17208263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.
    Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Valerie K; Dent P; Fisher PB
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10054-9. PubMed ID: 12114539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.
    Emdad L; Lebedeva IV; Su ZZ; Gupta P; Sauane M; Dash R; Grant S; Dent P; Curiel DT; Sarkar D; Fisher PB
    Cancer Biol Ther; 2009 Mar; 8(5):391-400. PubMed ID: 19276652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.
    Gupta P; Su ZZ; Lebedeva IV; Sarkar D; Sauane M; Emdad L; Bachelor MA; Grant S; Curiel DT; Dent P; Fisher PB
    Pharmacol Ther; 2006 Sep; 111(3):596-628. PubMed ID: 16464504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mda-7 (IL-24): signaling and functional roles.
    Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Dent P; Fisher PB
    Biotechniques; 2002 Oct; Suppl():30-9. PubMed ID: 12395925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells.
    Lebedeva IV; Su ZZ; Chang Y; Kitada S; Reed JC; Fisher PB
    Oncogene; 2002 Jan; 21(5):708-18. PubMed ID: 11850799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.
    Su Z; Lebedeva IV; Gopalkrishnan RV; Goldstein NI; Stein CA; Reed JC; Dent P; Fisher PB
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10332-7. PubMed ID: 11526239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine.
    Sauane M; Gopalkrishnan RV; Sarkar D; Su ZZ; Lebedeva IV; Dent P; Pestka S; Fisher PB
    Cytokine Growth Factor Rev; 2003 Feb; 14(1):35-51. PubMed ID: 12485618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
    Lebedeva IV; Emdad L; Su ZZ; Gupta P; Sauane M; Sarkar D; Staudt MR; Liu SJ; Taher MM; Xiao R; Barral P; Lee SG; Wang D; Vozhilla N; Park ES; Chatman L; Boukerche H; Ramesh R; Inoue S; Chada S; Li R; De Pass AL; Mahasreshti PJ; Dmitriev IP; Curiel DT; Yacoub A; Grant S; Dent P; Senzer N; Nemunaitis JJ; Fisher PB
    Int J Oncol; 2007 Nov; 31(5):985-1007. PubMed ID: 17912425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
    Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
    Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma differentiation-associated gene-7, MDA-7/IL-24, selectively induces growth suppression, apoptosis in human hepatocellular carcinoma cell line HepG2 by replication-incompetent adenovirus vector.
    Wang CJ; Xue XB; Yi JL; Chen K; Zheng JW; Wang J; Zeng JP; Xu RH
    World J Gastroenterol; 2006 Mar; 12(11):1774-9. PubMed ID: 16586551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells.
    Su Z; Emdad L; Sauane M; Lebedeva IV; Sarkar D; Gupta P; James CD; Randolph A; Valerie K; Walter MR; Dent P; Fisher PB
    Oncogene; 2005 Nov; 24(51):7552-66. PubMed ID: 16044151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.
    Dent P; Yacoub A; Hamed HA; Park MA; Dash R; Bhutia SK; Sarkar D; Gupta P; Emdad L; Lebedeva IV; Sauane M; Su ZZ; Rahmani M; Broaddus WC; Young HF; Lesniak M; Grant S; Curiel DT; Fisher PB
    Anticancer Drugs; 2010 Sep; 21(8):725-31. PubMed ID: 20613485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
    Sarkar D; Lebedeva IV; Su ZZ; Park ES; Chatman L; Vozhilla N; Dent P; Curiel DT; Fisher PB
    Cancer Res; 2007 Jun; 67(11):5434-42. PubMed ID: 17545625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus.
    Sarkar S; Azab B; Quinn BA; Shen X; Dent P; Klibanov AL; Emdad L; Das SK; Sarkar D; Fisher PB
    Curr Mol Med; 2014 Jan; 14(1):125-40. PubMed ID: 24236457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.
    Emdad L; Bhoopathi P; Talukdar S; Pradhan AK; Sarkar D; Wang XY; Das SK; Fisher PB
    Semin Cancer Biol; 2020 Nov; 66():140-154. PubMed ID: 31356866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
    Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
    Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.